Domain binding and isotype dictate the activity of anti-human OX40 antibodies.

Autor: Griffiths J; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Hussain K; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Smith HL; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Sanders T; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Cox KL; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Semmrich M; Preclinical Research, BioInvent International AB, Lund, Sweden., Mårtensson L; Preclinical Research, BioInvent International AB, Lund, Sweden., Kim J; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Inzhelevskaya T; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Penfold CA; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Tutt AL; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Mockridge CI; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Chan HC; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., English V; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., French RF; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Teige I; Preclinical Research, BioInvent International AB, Lund, Sweden., Al-Shamkhani A; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Glennie MJ; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Frendeus BL; Preclinical Research, BioInvent International AB, Lund, Sweden., Willoughby JE; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK msc@soton.ac.uk.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Dec; Vol. 8 (2).

一株G6P[5]型牛轮状病毒的分离鉴定与全基因组序列分析. (Chinese)

Autor: 曹存, 于德斌, 徐晓静, 于力, 常继涛

Publikováno v: Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao; 2021, Vol. 43 Issue 9, p939-945, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cambarus loughmani, a new species of crayfish (Decapoda: Cambaridae) endemic to the pre-glacial Teays River Valley in West Virginia, USA.

Autor: Foltz, David A.^1,2 dfoltz@westliberty.edu, Sadecky, Nicole M.^2,3, Myers, Greg A.², Fetzner, James W.⁴, Welsh, Stuart A.⁵, Stocker, G. Whitney⁶, Glon, Mael G.⁷, Thoma, Roger F.⁸

Publikováno v: Journal of Natural History. Dec2018, Vol. 52 Issue 45/46, p2875-2897. 23p.